MicroRNA-217, down-regulated in clear cell renal cell carcinoma and associated with lower survival, suppresses cell proliferation and migration

Neoplasma

Volumn 60, Issue 5, 2013, Pages 511-515

  Li, H ^a   Zhao, J ^a   Zhang, J W ^a   Huang, Q Y ^a   Huang, J Z ^a   Chi, L S ^a   Tang, H J ^a   Liu, G Q ^a   Zhu, D J ^a   Ma, W M ^a  

^a Maternity and Child Health Care Hospital of Foshan City   (China)

Author keywords

Clear cell renal cell carcinoma; Migration; miR 217; Proliferation; Survival

Indexed keywords

MICRORNA; MICRORNA 217; UNCLASSIFIED DRUG; MIRN217 MICRORNA, HUMAN; TUMOR MARKER;

ADULT; ARTICLE; CANCER GRADING; CANCER INHIBITION; CANCER SURVIVAL; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DOWN REGULATION; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; REAL TIME POLYMERASE CHAIN REACTION; RNA EXTRACTION; BIOSYNTHESIS; CELL MOTION; GENETIC TRANSFECTION; GENETICS; KAPLAN MEIER METHOD; KIDNEY TUMOR; MORTALITY; PATHOLOGY; PROGNOSIS; TUMOR CELL LINE;

CARCINOMA, RENAL CELL; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; DOWN-REGULATION; HUMANS; KAPLAN-MEIER ESTIMATE; KIDNEY NEOPLASMS; MICRORNAS; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; TRANSFECTION; TUMOR MARKERS, BIOLOGICAL;

EID: 84885485886     PISSN: 00282685     EISSN: 13384317     Source Type: Journal    
DOI: 10.4149/neo_2013_066     Document Type: Article

References (17)

1. JEMAL A, SIEGEL R, WARD E, HAO Y, XU J et al: Cancer statistics. CA Cancer J Clin 2008; 58: 71-96, http://dx.doi.org/10.3322/CA.2007.0010
2. RINI BI, CAMPBELL SC, ESCUDIER B: Renal cell carcinoma. Lancet 2009; 373: 1119-1132, http://dx.doi.org/10.1016/S0140-6736(09)60229-4
3. IORIO MV, CROCE CM: microRNA involvement in human cancer. Carcinogenesis 2012; 33: 1126-1133, http://dx.doi.org/10.1093/carcin/bgs140
4. MELO SA, ESTELLER M: Dysregulation of microRNAs in cancer: playing with fire. FEBS Lett 2011; 585: 2087-2099, http://dx.doi.org/10.1016/j.febslet.2010.08.009
5. SCHOOF CR, BOTELHO EL, IZZOTTI A, VASQUES L R: MicroRNAs in cancer treatment and prognosis. Am J Cancer Res 2012; 2: 414-433,
6. LIU Y, HAN Y, ZHANG H, NIE L, JIANG Z et al: Synthetic miRNA-Mowers Targeting miR-183-96-182 Cluster or miR-210 Inhibit Growth and Migration and Induce Apoptosis in Bladder Cancer Cells. 2012; PLoS One 7: e52280, http://dx.doi.org/10.1371/journal.pone.0052280
7. ZHOU L, CHEN J, LI Z, LI X, HU X et al: Integrated profiling of microRNAs and mRNAs: microRNAs located on Xq27. 3 associate with clear cell renal cell carcinoma. PLoS One 5: e15224,2010. http://dx.doi.org/10.1371/journal.pone.0015224
8. ZHAO WG, YU SN, LU ZH, MA YH, GU YM et al: The miR-217 microRNA functions as a potential tumor suppressor in pancreatic ductaladenocarcinoma by targeting KRAS. Carcinogenesis2010, 31: 1726-1733. http://dx.doi.org/10.1093/carcin/bgq160
9. GEORGIEVA B, MILEV I, MINKOV I, DIMITROVA I, BRADFORD AP et al: Characterization of the uterine leiomyoma microRNAome by deep sequencing. Genomics 2012; 99: 275-281. http://dx.doi.org/10.1016/j.ygeno.2012.03.003
10. KATO M, PUTTA S, WANG M, YUAN H, LANTING L et al: TGF-beta activates Akt kinase through a microRNA-dependent amplifying circuit targeting PTEN. Nat Cell Biol 2009; 11: 881-889. http://dx.doi.org/10.1038/ncb1897
11. ANINDO MI, YAQINUDDIN A: Insights into the potential use of microRNAs as biomarker in cancer. Int J Surg 2012; 10: 443-449. http://dx.doi.org/10.1016/j.ijsu.2012.08.006
12. OSANTO S, QIN Y, BUERMANS HP, BERKERS J, LERUT E et al: Genome-wide microRNA expression analysis of clear cell renal cell carcinoma by next generation deep sequencing. PLoS One 2012; 7: e38298. http://dx.doi.org/10.1371/journal.pone.0038298
13. WHITE NM, KHELLA HW, GRIGULL J: miRNA profiling in metastatic renal cell carcinoma reveals a tumour-suppressor effect for miR-215. Br J Cancer 2011; 105: 1741-1749. http://dx.doi.org/10.1038/bjc.2011.401
14. AL-ALI BM, RESS AL, GERGER A, PICHLER M: MicroRNAs in renal cell carcinoma: implications for pathogenesis, diagnosis, prognosis and therapy. Anticancer Res 2012, 32: 3727-3732.
15. MENGHINI R, CASAGRANDE V, CARDELLINI M, MARTELLI E, TERRINONI A et al: MicroRNA 217 modulates endothelial cell senescence via silent information regulator 1. Circulation 2009,120: 1524-1532. http://dx.doi.org/10.1161/CIRCULATIONAHA.109.864629
16. YIN H, HU M, ZHANG R, SHEN Z, FLATOW L et al: MicroRNA-217 promotes ethanol-induced fat accumulation in hepatocytes by down-regulating SIRT1. J Biol Chem 2012; 287: 9817-9826. http://dx.doi.org/10.1074/jbc.M111.333534
17. ZHANG HS, WU TC, SANG WW, RUAN Z: MiR-217 is involved in Tat-induced HIV-1 long terminal repeat (LTR) transactivation by down-regulation of SIRT1. Biochim Biophys Acta 2012; 1823: 1017-1023.